IRIS Accounts Production v24.3.2.46 10263699 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh102636992023-06-30102636992024-06-30102636992023-07-012024-06-30102636992022-06-30102636992022-07-012023-06-30102636992023-06-3010263699ns15:EnglandWales2023-07-012024-06-3010263699ns14:PoundSterling2023-07-012024-06-3010263699ns10:Director12023-07-012024-06-3010263699ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3010263699ns10:SmallEntities2023-07-012024-06-3010263699ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3010263699ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3010263699ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3010263699ns10:FullAccounts2023-07-012024-06-301026369912023-07-012024-06-3010263699ns10:Director22023-07-012024-06-3010263699ns10:RegisteredOffice2023-07-012024-06-3010263699ns5:CurrentFinancialInstruments2024-06-3010263699ns5:CurrentFinancialInstruments2023-06-3010263699ns5:Non-currentFinancialInstruments2024-06-3010263699ns5:Non-currentFinancialInstruments2023-06-3010263699ns5:ShareCapital2024-06-3010263699ns5:ShareCapital2023-06-3010263699ns5:RetainedEarningsAccumulatedLosses2024-06-3010263699ns5:RetainedEarningsAccumulatedLosses2023-06-3010263699ns5:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3010263699ns5:ComputerSoftware2023-07-012024-06-3010263699ns5:LeaseholdImprovements2023-07-012024-06-3010263699ns5:FurnitureFittings2023-07-012024-06-3010263699ns5:ComputerEquipment2023-07-012024-06-3010263699ns5:IntangibleAssetsOtherThanGoodwill2023-06-3010263699ns5:IntangibleAssetsOtherThanGoodwill2024-06-3010263699ns5:IntangibleAssetsOtherThanGoodwill2023-06-3010263699ns5:LeaseholdImprovements2023-06-3010263699ns5:FurnitureFittings2023-06-3010263699ns5:ComputerEquipment2023-06-3010263699ns5:LeaseholdImprovements2024-06-3010263699ns5:FurnitureFittings2024-06-3010263699ns5:ComputerEquipment2024-06-3010263699ns5:LeaseholdImprovements2023-06-3010263699ns5:FurnitureFittings2023-06-3010263699ns5:ComputerEquipment2023-06-3010263699ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3010263699ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-3010263699ns5:WithinOneYear2024-06-3010263699ns5:WithinOneYear2023-06-3010263699ns5:BetweenOneFiveYears2024-06-3010263699ns5:BetweenOneFiveYears2023-06-3010263699ns5:MoreThanFiveYears2024-06-3010263699ns5:MoreThanFiveYears2023-06-3010263699ns5:AllPeriods2024-06-3010263699ns5:AllPeriods2023-06-30
REGISTERED NUMBER: 10263699 (England and Wales)















Financial Statements for the Year Ended 30 June 2024

for

Harrogate Pharmacy Limited

Harrogate Pharmacy Limited (Registered number: 10263699)






Contents of the Financial Statements
for the Year Ended 30 June 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Harrogate Pharmacy Limited

Company Information
for the Year Ended 30 June 2024







DIRECTORS: J E Lestner
D A Lestner





REGISTERED OFFICE: 50-52 Station Road
Harrogate
West Yorkshire
HG1 1TX





REGISTERED NUMBER: 10263699 (England and Wales)





ACCOUNTANTS: Richard Smedley Limited
Chartered Accountants & Registered Auditors
Richmond House
Lawnswood Business Park
Redvers Close
Leeds
West Yorkshire
LS16 6QY

Harrogate Pharmacy Limited (Registered number: 10263699)

Balance Sheet
30 June 2024

30.6.24 30.6.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 27,597 18,479
27,597 18,479

CURRENT ASSETS
Stocks 124,200 109,500
Debtors 6 335,026 317,690
Cash at bank 24,677 -
483,903 427,190
CREDITORS
Amounts falling due within one year 7 777,611 619,891
NET CURRENT LIABILITIES (293,708 ) (192,701 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(266,111

)

(174,222

)

CREDITORS
Amounts falling due after more than one
year

8

15,420

20,323
NET LIABILITIES (281,531 ) (194,545 )

CAPITAL AND RESERVES
Called up share capital 300 300
Retained earnings (281,831 ) (194,845 )
(281,531 ) (194,545 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Harrogate Pharmacy Limited (Registered number: 10263699)

Balance Sheet - continued
30 June 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 March 2025 and were signed on its behalf by:





J E Lestner - Director


Harrogate Pharmacy Limited (Registered number: 10263699)

Notes to the Financial Statements
for the Year Ended 30 June 2024

1. STATUTORY INFORMATION

Harrogate Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The accounts are prepared on a going concern basis due to continued support of the shareholders and creditors.

Turnover
Turnover comprises the value of sales (excluding VAT, similar taxes and trade discounts) of goods and services provided in the normal course of business. Wholesale sales and prescriptions are recognised when the goods are dispensed.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of three years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - Over the term of the lease
Fixtures and fittings - 25% on reducing balance
Computer equipment - Straight line over 3 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Basic financial instruments are recognised at amortised costs. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Harrogate Pharmacy Limited (Registered number: 10263699)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2023 - 13 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 July 2023
and 30 June 2024 27,670
AMORTISATION
At 1 July 2023
and 30 June 2024 27,670
NET BOOK VALUE
At 30 June 2024 -
At 30 June 2023 -

Harrogate Pharmacy Limited (Registered number: 10263699)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to and Computer
property fittings equipment Totals
£    £    £    £   
COST
At 1 July 2023 35,115 29,284 5,260 69,659
Additions 14,345 887 2,398 17,630
At 30 June 2024 49,460 30,171 7,658 87,289
DEPRECIATION
At 1 July 2023 31,095 14,825 5,260 51,180
Charge for year 3,874 3,839 799 8,512
At 30 June 2024 34,969 18,664 6,059 59,692
NET BOOK VALUE
At 30 June 2024 14,491 11,507 1,599 27,597
At 30 June 2023 4,020 14,459 - 18,479

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.24 30.6.23
£    £   
Trade debtors 226,380 175,367
Other debtors 108,646 142,323
335,026 317,690

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.24 30.6.23
£    £   
Bank loans and overdrafts 221,358 192,820
Trade creditors 326,340 207,072
Taxation and social security 4,474 2,956
Other creditors 225,439 217,043
777,611 619,891

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.6.24 30.6.23
£    £   
Bank loans 15,420 20,323

Harrogate Pharmacy Limited (Registered number: 10263699)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024

9. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
30.6.24 30.6.23
£    £   
Within one year 32,000 3,013
Between one and five years 32,000 -
In more than five years 69,333 -
133,333 3,013

10. SECURED DEBTS

National Westminster Bank PLC hold a fixed and floating charge over property, assets and rights of the company.

RX Bridge Ltd hold a fixed and floating charge over property, assets and rights of the company.